cagrilintide and semaglutide 2.4mg.... Once-weekly for weight management in people with overweight obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial Cagrilintide / Semaglutide Blend (5mg

J Biomed 3:7484

R#56 (conditional): Botulinum toxin injections should be considered as an option in the case of persistent focal dystonia in AD-GTPCHD if all first- and second-line treatment options have, over an adequate amount of time, shown to be insufficient to control these symptoms

Although the precise pathogenesis of brain dysfunction is still unclear, there is strong rationale for reducing HPA and maintaining satisfactory low Phe levels in all BH 4 Ds with HPA [120]

BPC-157 (Body Protection Compound-157) is a synthetic peptide made of 15 amino acids (a pentadecapeptide) derived from a protective protein naturally found in gastric juice and the stomach lining